Quick Answer
INTEGRATED BIOPHARMA INC reported Gross Profit of $5.56 million for fiscal year 2025.
INTEGRATED BIOPHARMA INC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $5.56M | +43.2% |
| 2024 | $3.88M | -4.4% |
| 2023 | $4.06M | -38.0% |
| 2022 | $6.55M | -30.9% |
| 2021 | $9.48M | +40.9% |
| 2020 | $6.73M | +8.1% |
| 2019 | $6.22M | +24.7% |
| 2018 | $4.99M | -25.2% |
| 2017 | $6.67M | +21.1% |
| 2016 | $5.50M | +25.3% |
| 2015 | $4.39M | -10.0% |
| 2014 | $4.88M | -11.2% |
| 2013 | $5.50M | -27.7% |
| 2012 | $7.61M | -25.1% |
| 2011 | $10.16M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $29.0K | -97.5% | -97.2% |
| September 30, 2025 | $1.02M | -25.7% | -34.3% |
| March 31, 2025 | $1.55M | +24.3% | +32.5% |
| December 31, 2024 | $1.17M | +125.2% | -14.6% |
| September 30, 2024 | $1.37M | +64.8% | +9.9% |
| March 31, 2024 | $1.25M | +23.8% | +140.0% |
| December 31, 2023 | $520.0K | -51.4% | -37.5% |
| September 30, 2023 | $832.0K | -16.5% | -17.5% |
- INTEGRATED BIOPHARMA INC showed an increase of +43.2% in Gross Profit compared to the prior fiscal year.
- Over the 2011–2025 period, INTEGRATED BIOPHARMA INC’s gross profit has declined by 45.3% (from $10.16 million to $5.56 million).
- The most recent figure is from INTEGRATED BIOPHARMA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: